Innovative Research Award
Francisco Giner
University of Valencia, Spain
Francisco Giner is a researcher affiliated with the University of Valencia whose academic work contributes to cancer research through scientific publications, interdisciplinary collaboration, and evidence-based investigation. His publication record and citation impact demonstrate sustained scholarly engagement, making his profile relevant for consideration within the International Research Awards program.[1]
Abstract
Francisco Giner has established a recognized academic profile through continuous contributions to cancer research at the University of Valencia. His scholarly activities include scientific publications, collaborative investigations, and research focused on improving knowledge within oncology. Supported by a publication record of sixty-seven indexed documents, six hundred sixty-six citations, and an h-index of sixteen, his work reflects measurable scientific influence. These achievements demonstrate sustained research productivity, academic collaboration, and commitment to advancing evidence-based cancer science, supporting his suitability for recognition through the International Research Awards.[1]
Keywords
Cancer Research, Oncology, Scientific Publications, Research Excellence, Innovation, Translational Medicine, Biomedical Science, Scopus, Academic Impact, International Research Awards.
Introduction
Cancer research continues to advance through multidisciplinary investigation, technological innovation, and collaborative scientific discovery. Researchers with consistent publication records contribute to expanding biomedical knowledge while supporting improvements in diagnosis, treatment, and patient outcomes. Francisco Giner’s academic profile reflects these objectives through sustained scholarly engagement and measurable research performance.[1]
Research Profile
As a researcher at the University of Valencia, Francisco Giner has developed expertise within the field of cancer research while contributing to peer-reviewed scientific literature. His Scopus-indexed publication record demonstrates continuous academic productivity, collaborative research involvement, and sustained participation in internationally recognized scientific activities.[1]
Research Contributions
The research contributions associated with Francisco Giner emphasize scientific investigation within oncology and related biomedical disciplines. His published studies support evidence-based understanding while encouraging collaborative research, methodological development, and continued advancement of cancer science through high-quality academic outputs.[2]
Publications
Francisco Giner has produced sixty-seven indexed publications that collectively demonstrate sustained scientific productivity. These publications contribute to the international research community by presenting peer-reviewed findings, supporting collaborative scholarship, and expanding the evidence base within cancer-related scientific investigation.[1]
Research Impact
Citation indicators provide quantitative evidence of research visibility and scholarly influence. Francisco Giner’s citation count and h-index illustrate that his published work has been referenced by other researchers, reflecting continued academic relevance and contribution to the advancement of cancer research literature.[4]
Award Suitability
The Innovative Research Award recognizes sustained academic excellence, research productivity, and meaningful scientific contributions. Francisco Giner’s publication record, citation performance, institutional affiliation, and commitment to cancer research align with commonly recognized indicators considered for international academic recognition programs.[3]
Conclusion
Francisco Giner’s documented research achievements illustrate a consistent commitment to scientific excellence within cancer research. His measurable academic performance, scholarly publications, and research influence collectively support recognition through the International Research Awards while reflecting continued contributions to biomedical science.[5]
External Links
References
- Elsevier. (n.d.). Scopus author details: Francisco Giner, Author ID 24469769300. Scopus.
https://www.scopus.com/pages/authors/24469769300
- International Research Awards. (n.d.). Innovative Research Award Program.
https://researchawards.net/
- Medina-Ceballos, E., Giner, F., Machado, I., Heras-Morán, B., Espino, M., Navarro, S., & Llombart-Bosch, A. (2025). The prognostic impact of the tumor immune microenvironment in synovial sarcoma: An immunohistochemical analysis using digital pathology and conventional interpretation. Journal of Personalized Medicine, 15(5), 169.
https://doi.org/10.3390/jpm15050169
- Arencibia-Pérez, B., Giner, F., García-Granero, E., Roselló-Keränen, S., Flor-Lorente, B., Cervantes, A., Sancho-Muriel, J., & Frasson, M. (2025). The degree of extramural spread of T3 colon cancer as a prognostic factor: Another appeal to the American Joint Committee on Cancer. Cancer Medicine. Advance online publication.
https://doi.org/10.1002/cam4.70720
- Machado, I., López-Reig, R., Giner, E., Fernández-Serra, A., Requena, C., Llombart, B., Giner, F., Cruz, J., Traves, V., Lavernia, J., Llombart-Bosch, A., & López Guerrero, J. A. (2025). Integration of an OS-based machine learning score (AS score) and Immunoscore as ancillary tools for predicting immunotherapy response in sarcomas. Cancers, 17(15), 2551.
https://doi.org/10.3390/cancers17152551